NU656 · Unit 8

NU656 Unit 8 acute kidney injury case example

AGACNP Critical Care Management Purdue University Global Free custom sample in 24 to 48h

[Thirty-six] hours after induction chemotherapy for a high-grade lymphoma, a composite [27]-year-old man has made [180] mL of urine in [eight] hours, and his potassium reads [6.3] mEq/L. The NU656 Unit 8 acute kidney injury case stages the injury by KDIGO criteria, names tumor lysis as its cause and sets the point at which dialysis stops being a question.

What this page holds

KDIGO stage 2 by creatinine, clinical tumor lysis by Cairo-Bishop criteria and dialysis triggers written before they are reached organize this NU656 Unit 8 kidney injury case. Searches like "nu 656 unit 8 assignment example", "nu656 unit 8 sample" and "nu656 unit 8 example" land here.

What a finished NU656 Unit 8 acute kidney injury case looks like

Four pages, five headings. A laboratory table opens it with baseline and current values side by side: creatinine [0.9] and [2.1] mg/dL, potassium [4.1] and [6.3], phosphate [3.8] and [9.1] mg/dL, calcium [9.2] and [6.9] mg/dL, uric acid [7.0] and [14.2] mg/dL, with urine output charted hourly against a weight of [78] kg. The staging section works the numbers: a creatinine ratio of [2.33], and urine at [0.29] mL/kg/h for [eight] hours. Diagnosis follows under the definition published by Cairo and Bishop in 2004, laboratory then clinical. A management section covers rasburicase after a G6PD check, fluids, and the hyperkalemia with its ECG. Triggers for renal replacement therapy fill the last section, citing KDIGO 2012 and the STARRT-AKI trial (NEJM, 2020).

How a NU656 Unit 8 example is structured

Staging comes before cause, because KDIGO grades by whichever criterion is worse, and the case uses both. Creatinine at [2.33] times baseline meets stage 2; urine output below [0.5] mL/kg/h for [eight] hours meets only stage 1, and the paper states that the higher stage governs. Cause follows: all four Cairo-Bishop laboratory criteria plus a creatinine above [1.5] times the upper limit of normal make this clinical tumor lysis. Management is ordered by threat. Potassium with peaked T waves is treated first, calcium gluconate included despite the phosphate level, because membrane stabilization outweighs precipitation risk. Uric acid follows with rasburicase, and asymptomatic hypocalcemia is deliberately left alone. The dialysis section carries the argument: STARRT-AKI found no benefit to accelerated dialysis in general critical illness, but ongoing cell lysis keeps releasing potassium, so the thresholds here are set lower and stated in numbers.

Creatinine against urine output

Creatinine gives stage 2, urine output gives stage 1, and the paper reports stage 2 with both calculations shown. It adds that [four] more hours below [39] mL an hour would bring the urine criterion to stage 2, and a full day under [23] mL an hour would reach stage 3.

Tumor lysis, defined rather than assumed

Uric acid, potassium, phosphate and calcium each cross their laboratory thresholds within the window after therapy began. The creatinine rise then upgrades the diagnosis from laboratory to clinical tumor lysis, the distinction the definition draws once an organ is affected.

Potassium first, calcium carefully

Peaked T waves justify calcium gluconate for the heart despite a calcium-phosphate product near [63]. Insulin with dextrose and a potassium binder follow, doses bracketed. Low calcium without symptoms is not corrected, and the paper explains the precipitation risk.

Uric acid and the enzyme

Rasburicase lowers uric acid within hours, which allopurinol cannot do for acid already formed. A G6PD result is documented before the dose, since deficiency makes the drug dangerous, and the paper notes that samples need ice to avoid falsely low readings.

Thresholds that start dialysis

Potassium at or above [6.0] despite treatment, phosphate still climbing, urine below [0.3] mL/kg/h for [six] hours, or fluid overload with falling oxygenation. Any one prompts a call to nephrology that day, and the paper explains why tumor lysis lowers the bar.

Where marks go in NU656 Unit 8

Staging is scored for method. A paper that reports stage 1 because urine output was the first number read, or stage 3 because the creatinine looks alarming, shows the criteria were not applied, and instructors check both calculations. Naming tumor lysis without the definition's criteria reads as a guess. The hyperkalemia plan draws close attention: withholding calcium because phosphate is high, when the ECG has changed, is marked as a safety error, while treating asymptomatic hypocalcemia is marked as the opposite error. Rasburicase given without a G6PD check loses credit. Much of the reasoning credit sits in the dialysis section, where a vague plan to dialyze if worse cannot be acted on, and a plan that ignores the trial evidence on timing misses the argument. A urine criterion computed without body weight costs a little.

Get a NU656 Unit 8 example written to your instructions

Baseline labs, today's labs and urine output, plus the rubric your NU656 Unit 8 section uses, are enough to begin. The case comes back within 24-48h at no cost for a first request, with both KDIGO criteria calculated, the cause defined by published criteria and dialysis triggers written as numbers a night team could act on.

NU656 Unit 8 questions, answered

Which KDIGO criterion wins when creatinine and urine output disagree?

The one giving the higher stage. KDIGO stages acute kidney injury by creatinine or by urine output, and the patient is assigned the more severe of the two. The sample shows both calculations, reports stage 2 from creatinine and notes how many more hours of low urine output would change the urine criterion. Many papers compute only one and understate the stage.

Why is dialysis considered earlier in tumor lysis than in other kidney injury?

Because the source of potassium and phosphate keeps releasing them as tumor cells break down. In general critical illness, STARRT-AKI found no survival benefit from starting dialysis early, and many patients recover without it. When lysis is ongoing and urine output is falling, the sample argues for lower thresholds and states them, while noting that the decision belongs to the treating team and nephrology.

Where does the case study's patient come from?

He was built for teaching from a pattern common after induction therapy, and every value sits in brackets. No dose or threshold in the sample is meant for a real patient. The case exists to show staging worked from both criteria, a cause defined by published criteria and a plan that says in numbers when dialysis begins.